San Diego, United States
Radicle Science is carving a niche in the Digital Health and Health and Wellness industries with its innovative approach to generating real-world, clinical-grade evidence. Founded in 2020 and headquartered in the United States, the company empowers health companies to validate their products efficiently and economically. Their model, termed “Proof-as-a-Service,” leverages large-scale decentralized trials and AI-driven analytics to streamline what was once a slow, expensive process, thereby speeding up innovation and enhancing competitive positioning.
With a focus on transparency and rapid delivery, Radicle Science has become a strategic partner for companies aiming to bolster market claims and spur adoption. The company last attracted investment during a Seed Round on 30 March 2022, with investors like ensemble and Everywhere Ventures (The Fund) backing its vision and growth trajectory. This investment is a testament to its potential impact on revolutionizing evidence-based validation in health-related sectors.
